9 Sources of evidence considered by the committee

9 Sources of evidence considered by the committee

The diagnostics assessment report was prepared by CRD/CHE Technology Assessment Group (Centre for Reviews and Dissemination/Centre for Health Economics), University of York.

  • Yang H, Saramago Goncalves P, Llewellyn A, et al. High-throughput, non‑invasive prenatal testing for fetal rhesus D status in RhD‑negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation. May 2016.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Provider of technologies included in the final scope:

  • International Blood Group Reference Laboratory

Other commercial organisations:

  • CSL Behring UK Ltd

Professional groups and patient/carer groups:

  • British Maternal and Fetal Medicine Society

  • British Society for Haematology

  • Royal College of Nursing

  • Royal College of Physicians

Research groups:

  • None

Associated guideline groups:

  • None


  • Department of Health

  • Healthcare Improvement Scotland

  • NHS England

  • Welsh Government

ISBN: 978-1-4731-2156-0

  • National Institute for Health and Care Excellence (NICE)